The present invention relates to novel compounds of the formula I which are inhibitors of phosphodiesterase type 10A and to their use for the manufacture of a medicament and which thus are suitable for treating or controlling of medical disorders selected from neurological disorders and psychiatric disorders, for ameliorating the symptoms associated with such disorders and for reducing the risk of such disorders.
本发明涉及一种新型化合物,其
化学式为I,它们是
磷酸二酯酶10A的
抑制剂,并且用于制备药物,因此适用于治疗或控制从神经系统疾病和精神疾病中选择的医学疾病,改善与这些疾病相关的症状,并减少这些疾病的风险。